IMUNO BCG Trademark

Trademark Overview


On Wednesday, December 4, 2024, a trademark application was filed for IMUNO BCG with the United States Patent and Trademark Office. The USPTO has given the IMUNO BCG trademark a serial number of 98885351. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, May 28, 2025. This trademark is owned by Fundação Ataulpho de Paiva. The IMUNO BCG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
imuno bcg

General Information


Serial Number98885351
Word MarkIMUNO BCG
Filing DateWednesday, December 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, May 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFundação Ataulpho de Paiva
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRio de Janeiro 20031003
BR

Trademark Events


Event DateEvent Description
Wednesday, December 4, 2024NEW APPLICATION ENTERED
Wednesday, December 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 23, 2025ASSIGNED TO EXAMINER
Wednesday, May 28, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 28, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED